Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagnostics.
about
Next-Generation Sequencing in Clinical Molecular Diagnostics of Cancer: Advantages and ChallengesAnalysis of Pre-Analytic Factors Affecting the Success of Clinical Next-Generation Sequencing of Solid Organ MalignanciesThe Utilization of Cytologic Fine-Needle Aspirates of Lung Cancer for Molecular Diagnostic TestingDetection of mutations in myeloid malignancies through paired-sample analysis of microdroplet-PCR deep sequencing data.Validation of multiple single nucleotide variation calls by additional exome analysis with a semiconductor sequencer to supplement data of whole-genome sequencing of a human population.Big data from small samples: Informatics of next-generation sequencing in cytopathology.The use of endobronchial ultrasound guided transbronchial needle aspiration specimens for next generation sequencing in non-small cell lung cancer: a clinical perspective.Chromosome t(7;11)(p15;p15) translocation in acute myeloid leukemia coexisting with multilineage dyspoiesis and mutations in NRAS and WT1: A case report and literature reviewMutation profiling in cholangiocarcinoma: prognostic and therapeutic implications.Retrospective review using targeted deep sequencing reveals mutational differences between gastroesophageal junction and gastric carcinomas.Designing a high-throughput somatic mutation profiling panel specifically for gynaecological cancers.Applicability of next generation sequencing technology in microsatellite instability testingMultiplatform comparison of molecular oncology tests performed on cytology specimens and formalin-fixed, paraffin-embedded tissue.Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.Efficiency of EGFR mutation analysis for small microdissected cytological specimens using multitech DNA extraction solution.Identification of major factors associated with failed clinical molecular oncology testing performed by next generation sequencing (NGS).Next-generation sequencing for molecular diagnosis of lung adenocarcinoma specimens obtained by fine needle aspiration cytologyFactors affecting the success of next-generation sequencing in cytology specimens.HER2/neu-directed therapy for biliary tract cancer.Effective quality management practices in routine clinical next-generation sequencing.Building a Robust Tumor Profiling Program: Synergy between Next-Generation Sequencing and Targeted Single-Gene TestingMolecular Heterogeneity of Ewing Sarcoma as Detected by Ion Torrent SequencingCytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung.Digital PCR Improves Mutation Analysis in Pancreas Fine Needle Aspiration Biopsy Specimens.Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service.Clinical Next Generation Sequencing for Precision Medicine in Cancer.Routine clinical mutation profiling using next generation sequencing and a customized gene panel improves diagnostic precision in myeloid neoplasms.Clinical outcomes based on multigene profiling in metastatic breast cancer patientsNext-generation sequencing of non-small cell lung cancer using a customized, targeted sequencing panel: Emphasis on small biopsy and cytology.Cancer biomarker discovery: current status and future perspectives.EGFR mutation testing using archival-stained smears in non-small cell lung carcinoma.Massively parallel DNA sequencing from routinely processed cytological smears.Somatic Mutation Screening Using Archival Formalin-Fixed, Paraffin-Embedded Tissues by Fluidigm Multiplex PCR and Illumina Sequencing.FNA smears as a potential source of DNA for targeted next-generation sequencing of lung adenocarcinomas.The use of FNA samples for whole-exome sequencing and detection of somatic mutations in breast cancer surgical specimens.Cancer diagnostics: The journey from histomorphology to molecular profiling.Challenges and opportunities of next-generation sequencing: a cytopathologist's perspective.Thyroid C-Cell Biology and Oncogenic Transformation.Advances in clinical next-generation sequencing: target enrichment and sequencing technologies.Optimizing the DNA yield for molecular analysis from cytologic preparations.
P2860
Q26782324-DA9A7098-A825-446C-B357-450AA525E68EQ26783605-167B71B5-17FE-41FB-ADA8-52D0439461C7Q26824315-6B8BA52F-CD64-4073-8189-66B726E80590Q30836256-155C59D9-368B-44C0-BE97-623EC42CF276Q30841756-92305BB1-A2C0-41C6-AEEB-4F265A9AA61FQ31146982-F76AD5ED-A681-4D78-BE4B-604B4467ED9EQ33639153-83B4C596-234D-4885-9AAC-12638607074BQ33684901-DD29482C-8F9B-414E-98CD-66226C452B62Q34764681-89C11998-6C58-46CF-8B03-C2FD67BCAF4DQ35067345-F03C203E-8B67-4B67-A45A-3E5A8E10EAF7Q35132338-9A81EB02-B0ED-47E8-8FE3-087BB803AD7CQ35227758-0751C12A-A730-416D-9F2B-11D7BDC3ED58Q35237841-C2D06212-69DE-4F8B-B03D-DD214A107670Q35584856-05002574-1193-4752-AED0-4251F15EBBB8Q35627638-CA9CCA9C-8985-4B88-8E1E-257D3D47D0C9Q35662768-BDCCDD5D-98CE-4A9B-8571-9C3482FF43A5Q35726787-8D41E328-2AE6-45DE-988B-DB5692D60FB4Q35730088-E91F3821-2069-4017-98D1-B7C2EE5A30FEQ35748129-B2EA14F2-4882-43E9-9D3E-4D4AC64E1B45Q35922622-925EE85E-9496-4530-BF86-0859E3EE9149Q35979104-1B68D747-1624-4A71-880A-D76AF970AD66Q35989684-C7BFA5FC-4411-4C29-A6E7-FE82FB4BA847Q36135533-16132E7D-5607-4F7B-A968-7C52CA654CC4Q36261430-2F1387E6-E50D-415D-9952-3B0DDABAB917Q36279825-B536A6E7-63A5-462A-991B-D5BF1E5142E8Q36613044-C5FBE507-F70D-49F3-A20D-B0B0FCEEC046Q37327426-36495B77-F440-4BEB-B7CE-DF016D4470D0Q37718221-612E582E-854C-40A1-97E4-C1AF631CC570Q37736978-FC7AD2AD-20FE-48CC-BFA2-A4580377D265Q38187679-2662B7EE-EEFA-4CE7-A9BE-09FD53F8F31FQ38379393-50DBDFFD-A2AE-4E06-98F7-D00F42A409FDQ38383838-AC0AB1BF-3E33-41B1-989A-6C69AABBB23EQ38385507-DC0A579D-89F6-4FEA-8A14-3238486BEDEBQ38409652-4E5D533E-4F3C-4D78-9D02-2D7894158503Q38423398-3E04D9A2-F764-4D93-A36C-1A51314E3687Q38559476-E64886D5-5C0F-4925-8412-CA80B1F4629BQ38591866-5B0C6BC9-7F1A-4FF5-A624-C50A11B6915EQ38614485-E293091B-0642-40F8-A1E4-3B88C4B632D9Q38672934-57CA541C-8A31-469E-AC0D-AF83169DDAA8Q38814876-81D7F15F-AE7A-45B3-9C06-FCA5B939700F
P2860
Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagnostics.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Next-generation sequencing-bas ...... routine clinical diagnostics.
@en
Next-generation sequencing-bas ...... routine clinical diagnostics.
@nl
type
label
Next-generation sequencing-bas ...... routine clinical diagnostics.
@en
Next-generation sequencing-bas ...... routine clinical diagnostics.
@nl
prefLabel
Next-generation sequencing-bas ...... routine clinical diagnostics.
@en
Next-generation sequencing-bas ...... routine clinical diagnostics.
@nl
P2093
P2860
P1433
P1476
Next-generation sequencing-bas ...... routine clinical diagnostics.
@en
P2093
Abhaya V Paladugu
Bal M Mishra
Bedia A Barkoh
Brian A Handal
Bryce P Portier
Gregg A Staerkel
Hamed Rahimi
Jawad H Manekia
Kenneth D Aldape
Keyur P Patel
P2860
P2888
P304
P356
10.1038/MODPATHOL.2013.122
P577
2013-08-02T00:00:00Z